+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Stroke"

From
Atrial Fibrillation Market - Forecast from 2026 to 2031 - Product Thumbnail Image

Atrial Fibrillation Market - Forecast from 2026 to 2031

  • Report
  • January 2026
  • 143 Pages
  • Global
From
Neurorehabilitation Devices Market - Forecast from 2026 to 2031 - Product Thumbnail Image

Neurorehabilitation Devices Market - Forecast from 2026 to 2031

  • Report
  • January 2026
  • 150 Pages
  • Global
From
Neurorehabilitation Market - Forecast from 2026 to 2031 - Product Thumbnail Image

Neurorehabilitation Market - Forecast from 2026 to 2031

  • Report
  • January 2026
  • 151 Pages
  • Global
From
From
From
From
From
From
From
From
From
Loading Indicator

Stroke is a medical condition that occurs when the blood supply to the brain is interrupted, resulting in the death of brain cells. It is the leading cause of disability and the fifth leading cause of death in the United States. Cardiology is the branch of medicine that deals with the diagnosis and treatment of diseases of the heart and blood vessels. Stroke is a major focus of cardiology, as it is a major cause of death and disability. Stroke is a major focus of cardiology research, with a variety of treatments and therapies being developed to reduce the risk of stroke and improve outcomes for those who have suffered a stroke. There are a number of companies that are involved in the development and delivery of stroke treatments and therapies, including pharmaceutical companies, medical device companies, and biotechnology companies. Examples of companies in the stroke market include AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more